Abbreviations
- SLE:
-
Systemic lupus erythematosus
- SS:
-
Systemic sclerosis
References
Murata I, Takenaka K, Shinohara S, Suzuki T, Sasaki T, Yamamoto K (1998) Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients. Am Heart J 135:960–969
Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519
Kelly JD, Forster AM, Higley B et al. (1993) Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 34:222–227
Flamen P, Bossuyt A, Franken PR (1995) Technetium-99m-tetrofosmin in dipyridamole- stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 36:2009–2015
Schinkel AF, Elhendy A, van Domburg RT et al. (2003) Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol 91:408–411
Shaw LJ, Hendel R, Borges-Neto S et al. (2003) Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 44:134–139
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hsu, HB., Kao, CH. Usefulness of technetium-99m tetrofosmin SPECT to detect abnormal myocardial perfusion in systemic lupus erythematosus or systemic sclerosis patients. Clin Rheumatol 22, 495 (2003). https://doi.org/10.1007/s10067-003-0754-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-003-0754-x